The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis

Immunological Reviews

Volumn 164, Issue , 1998, Pages 93-100

  Tuohy, Vincent K ^a   Yu, Min ^a   Yin, Ling ^a   Kawczak, Julie A ^a   Johnson, Justin M ^a   Mathisen, Peter M ^a   Weinstock Guttman, Bianca ^a   Kinkel, R Philip ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; HLA DP ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE INJURY;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; HLA-DP ANTIGENS; HUMANS; IMMUNE TOLERANCE; MICE; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 0031726374     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01211.x     Document Type: Article

References (41)

1. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996;85:299-302.
2. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10:153-187.
3. Tuohy VK, Fritz RB. Ben-Nun A. Self-determinants in autoimmune demyelinating disease: changes in T-cell response specificity. Curr Opin Immunol 1994;6:887-891.
4. Vanderlugt CJ, Miller SD. Epitope spreading. Curr Opin Immunol 1996;8:831-836.
5. McCarron RM, Fallis RJ, McFarlin DE. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol 1990;29:73-79.
6. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-157.
7. 1s. J Immunol 1994;152:3711-3719.
8. Mor F, Cohen IR. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis. J Clin Invest 1993;92:2199-2206.
9. Perry LL, Barzaga-Gilbert E, Trotter JL. T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis. J Neuroimmunol 1991;33:7-15.
10. Cross AH, Tuohy VK, Raine CS. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell Immunol 1993;146:261-269.
11. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182:75-85.
12. Yu M, Nishiyama A, Trapp BD, Tuohy VK. Interferon-beta inhibits progression of relapsing-rernitting experimental autoimmune encephalomyelitis. J Neuroimmunol 1996;64:91-100.
13. Kono DH, Urban JL, Horvath SJ, Ando DG, Saavedra RA, Hood L. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J Exp Med 1988;168:213-227.
14. Sakai K, Zamvil SS, Mitchell DJ, Lim M, Rothbard JB, Steinman L. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J Neuroimmunol 1988;19:21-32.
15. Cross AH, Hashim GA, Raine CS. Adoptive transfer of experimental allergic encephalomyelitis and localization of the encephalitogenic epitope in the SWR mouse. J Neuroimmunol 1991;31:59-66.
16. Amor S, et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994;153:4349-1456.
17. Yu M, Johnson JM, Tuohy VK. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J Exp Med 1996;183:1777-1788.
18. Tuohy VK, Thomas DM. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. J Neuroimmunol 1995;56:161-170.
19. 1 mice with acute experimental allergic encephalomyelitis induced with two different synthetic peptides of myelin proteolipid protein. J Immunol 1991;146:543-549.
20. Yu M, Johnson JM, Tuohy VK. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. J Neurosci Res 1996;45:463-470.
21. Morrissey SP, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 1993;116:135-146.
22. Filippi M, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994;44:635-641.
23. Beck RW, et al. The effect of corticosteroid for acute optic neuritis on the subsequent development of multiple sclerosis. N Eng J Med 1993;329:1764-1769.
24. Tuohy VK, Yu M, Weinstock-Guttman B, Kinkel RE Diversity and plasticity of self-recognition during the development of multiple sclerosis. J Clin Invest 1997;99:1682-1690.
25. Yu M, Kinkel RP, Weinstock-Guttman B, Cook DJ, Tuohy VK. HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis. Hum Immunol 1998;59:15-24.
26. Francis DA, et al. Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ? Hum Immunol 1991;32:119-124.
27. Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, Gyllensten U Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994;39:41-48.
28. Odum N, Hyldig-Nielsen JJ, Morling N, Sandberg-Wollheim M, Platz P, Svejgaard A. HLA-DP antigens are involved in the susceptibility to multiple sclerosis. Tissue Antigens 1988;31:235-237.
29. Fugger L, et al. DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis. Immunogenetics 1990;32:150-156.
30. Olerup O, Hillert J, Fredrikson S. The HLA-D region-associated MS-susceptibility genes may be located telomeric to the HLA-DP subregion. Tissue Antigens 1990;36:37-39.
31. Wucherpfennig KW Weiner HL, Hafler DA. T-cell recognition of myelin basic protein. Immunol Today 1991;12:277-282.
32. Olerup O, et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989;86:7113-7117.
33. Valli A, et al. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest 1993;91:616-628.
34. + T cells from multiple sclerosis patients. J Neuroimmunol 1993;46:33-42.
35. Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel RP. Progression of experimental autoimmune encephalomyelitis and multiple sclerosis is accompanied by the decline of primary autoreactivity and the emergence of the epitope spreading cascade. (Submitted).
36. Baxevanis CN, et al. Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis. J Neuroimmunol 1989;22:23-30.
37. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990;346:183-187.
38. + cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol 1992;148:1359-1366.
39. + T cells from multiple sclerosis patients. J Neuroimmunol 1994;53:153-161.
40. Markovic-Plese S, et al. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol 1995;155:982-992.
41. Kerlero de Rosbo N, Milo R, Lees MB, Burger D, Bernard CC, Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 1993;92:2602-2608.